SCI Pharmtech (4119.TW) Earnings Analysis
SCI Pharmtech (4119.TW) next reports earnings on 2026-08-06. Last quarter (2026-03-05) it missed with EPS 0.33 TWD vs 0.42 TWD est (-21.4%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 60.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4119.TW next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
4119.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | 0.33 TWD | 0.42 TWD | -21.4% | Miss |
| 2025-11-07 | 0.12 TWD | 0.47 TWD | -74.5% | Miss |
| 2025-05-12 | 0.26 TWD | 0.26 TWD | 0% | Beat |
| 2025-03-10 | 0.3919 TWD | n/a | n/a | n/a |
| 2024-11-08 | 3.18 TWD | n/a | n/a | n/a |
| 2024-08-09 | 0.52 TWD | n/a | n/a | n/a |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
4119.TW valuation and analyst view
| Trailing P/E | 60.68 |
|---|---|
| Trailing EPS | 0.80118 TWD |
| Price / book | 1.09 |
| Dividend yield | 1.53% |
| Market cap | 5.95B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is SCI Pharmtech (4119.TW)'s next earnings date?
SCI Pharmtech is next scheduled to report on 2026-08-06.
Did 4119.TW beat earnings last quarter?
In its 2026-03-05 report, 4119.TW posted EPS of 0.33 TWD versus a 0.42 TWD estimate — a miss of 21.4%.
What is 4119.TW's earnings track record?
Over the last 3 reported quarters with consensus data, 4119.TW beat estimates 1 times (33%).
What is 4119.TW's current P/E ratio and EPS?
4119.TW trades at a trailing P/E of 60.68 on trailing EPS of 0.8011781539465647 TWD.
What do analysts rate 4119.TW?
4119.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.